Primary Site >> Liver Cancer
Gene >> CCR2
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. PMID: 15661146 Ref: Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. PMID: 16344072 |
Ref: Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization. PMID: 16052523 |
Ref: [Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials]. PMID: 17456312 |
Ref: [Expression of MCP/CCR2 in patients of hepatocellular carcinoma and liver cirrhosis]. PMID: 19912695 |
Ref: Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells. PMID: 19642141 Ref: Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients. PMID: 19720422 |
Ref: CC chemokine ligand 7 expression in liver metastasis of colorectal cancer. PMID: 22614322 |
Ref: Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis. PMID: 23081697 |
Ref: A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma. PMID: 24332572 Ref: Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma. PMID: 25091997 |
Ref: Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially. PMID: 25891236 |
Ref: FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling. PMID: 27216177 Ref: Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression. PMID: 27728804 |
Ref: Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. PMID: 26452628 Ref: Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model. PMID: 27980102 Ref: Peri-tumor associated fibroblasts promote intrahepatic metastasis of hepatocellular carcinoma by recruiting cancer stem cells. PMID: 28716525 Ref: A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer. PMID: 28754304 |
Ref: Alveolar Macrophages Drive Hepatocellular Carcinoma Lung Metastasis by Generating Leukotriene B4. PMID: 29378914 Ref: Monocytes/Macrophages promote vascular CXCR4 expression via the ERK pathway in hepatocellular carcinoma. PMID: 29399411 Ref: Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM model of NASH. PMID: 29847555 Ref: Recruitment of CCR2(+) tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer. PMID: 30228938 Ref: An update on the recent advances in antifibrotic therapy. PMID: 30261763 |